Genetic Technologies Limited (GENE)
NASDAQ: GENE · Real-Time Price · USD
0.765
0.00 (0.00%)
Nov 14, 2024, 4:00 PM EST - Market closed
Genetic Technologies Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Operating Revenue | 7.66 | 7.66 | 8.69 | 6.79 | 0.12 | 0.01 | Upgrade
|
| Other Revenue | 2.01 | 2.01 | 1.66 | 2.42 | 1.21 | 0.83 | Upgrade
|
| Revenue | 9.67 | 9.67 | 10.35 | 9.22 | 1.33 | 0.84 | Upgrade
|
| Revenue Growth (YoY) | -6.52% | -6.52% | 12.25% | 590.65% | 59.30% | 3192.98% | Upgrade
|
| Cost of Revenue | 3.76 | 3.76 | 4.34 | 3.01 | 0.17 | 0.1 | Upgrade
|
| Gross Profit | 5.91 | 5.91 | 6.01 | 6.2 | 1.16 | 0.74 | Upgrade
|
| Selling, General & Admin | 11.7 | 11.7 | 10.52 | 9.75 | 5.77 | 4.38 | Upgrade
|
| Research & Development | 0.75 | 0.75 | 1.28 | 0.71 | 1.17 | 0.87 | Upgrade
|
| Other Operating Expenses | 3.52 | 3.52 | 3.67 | 2.15 | 1.24 | 1.17 | Upgrade
|
| Operating Expenses | 16.51 | 16.51 | 16.43 | 13.75 | 8.59 | 6.67 | Upgrade
|
| Operating Income | -10.59 | -10.59 | -10.42 | -7.54 | -7.42 | -5.94 | Upgrade
|
| Interest Expense | -0.05 | -0.05 | -0.03 | -0.02 | -0.02 | -0.07 | Upgrade
|
| Interest & Investment Income | 0.12 | 0.12 | 0.22 | 0.04 | 0.06 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.16 | -0.16 | 0.16 | 0.36 | 0.01 | -0.6 | Upgrade
|
| EBT Excluding Unusual Items | -10.69 | -10.69 | -10.06 | -7.16 | -7.37 | -6.58 | Upgrade
|
| Impairment of Goodwill | -1.33 | -1.33 | -1.85 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.04 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.29 | 0.25 | Upgrade
|
| Pretax Income | -12.02 | -12.02 | -11.91 | -7.16 | -7.08 | -6.29 | Upgrade
|
| Income Tax Expense | - | - | -0.16 | -0.03 | - | - | Upgrade
|
| Earnings From Continuing Operations | -12.02 | -12.02 | -11.75 | -7.13 | -7.08 | -6.29 | Upgrade
|
| Net Income | -12.02 | -12.02 | -11.75 | -7.13 | -7.08 | -6.29 | Upgrade
|
| Net Income to Common | -12.02 | -12.02 | -11.75 | -7.13 | -7.08 | -6.29 | Upgrade
|
| Shares Outstanding (Basic) | 132 | 132 | 101 | 92 | 85 | 42 | Upgrade
|
| Shares Outstanding (Diluted) | 132 | 132 | 101 | 92 | 85 | 42 | Upgrade
|
| Shares Change (YoY) | 30.42% | 30.42% | 9.95% | 7.91% | 105.63% | 57.66% | Upgrade
|
| EPS (Basic) | -0.09 | -0.09 | -0.12 | -0.08 | -0.08 | -0.15 | Upgrade
|
| EPS (Diluted) | -0.09 | -0.09 | -0.12 | -0.08 | -0.08 | -0.15 | Upgrade
|
| Free Cash Flow | -9.71 | -9.71 | -9.74 | -5.72 | -7.04 | -5.75 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.07 | -0.10 | -0.06 | -0.08 | -0.14 | Upgrade
|
| Gross Margin | 61.12% | 61.12% | 58.10% | 67.31% | 87.23% | 87.89% | Upgrade
|
| Operating Margin | -109.52% | -109.52% | -100.66% | -81.84% | -556.03% | -708.77% | Upgrade
|
| Profit Margin | -124.24% | -124.24% | -113.56% | -77.36% | -530.26% | -751.29% | Upgrade
|
| Free Cash Flow Margin | -100.41% | -100.41% | -94.13% | -62.09% | -527.79% | -686.29% | Upgrade
|
| EBITDA | -10.36 | -10.36 | -10.04 | -7.2 | -7.16 | -5.87 | Upgrade
|
| EBITDA Margin | -107.07% | -107.07% | -96.99% | -78.11% | - | - | Upgrade
|
| D&A For EBITDA | 0.24 | 0.24 | 0.38 | 0.34 | 0.27 | 0.07 | Upgrade
|
| EBIT | -10.59 | -10.59 | -10.42 | -7.54 | -7.42 | -5.94 | Upgrade
|
| EBIT Margin | -109.52% | -109.52% | -100.66% | -81.84% | - | - | Upgrade
|
| Advertising Expenses | 2.61 | 2.61 | 2.71 | 1.89 | 0.44 | 0.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.